Irbesartan, an angiotensin II type 1 receptor blocker, inhibits colitis-associated tumourigenesis by blocking the MCP-1/CCR2 pathway
2021 · Scientific Reports · 23 citations
https://doi.org/10.1038/s41598-021-99412-8
M
Misao Yoneda
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
70
Papers
931
Citations
17
h-index
24
i10-index
Misao Yoneda is an academic researcher from Suzuka University of Medical Science. The author has contributed to research in topics: Neuroendocrine Tumor Research Advances & Pancreatic and Hepatic Oncology Research & Gastric Cancer Management and Outcomes. The author has an h-index of 17, co-authored 60 publications.
Papers by this author
worksMorphological characteristics of basal-like subtype of breast carcinoma with special reference to cytopathological features
2009 · Breast Cancer · 22 citations
https://doi.org/10.1007/s12282-009-0108-x
Characteristics of bone strength and metabolism in type 2 diabetic model Tsumura, Suzuki, Obese Diabetes mice
2018 · Bone Reports · 13 citations
https://doi.org/10.1016/j.bonr.2018.07.004
Pravastatin prevents colitis-associated carcinogenesis by reducing CX3CR1high M2-like fibrocyte counts in the inflamed colon
2024 · Scientific Reports · 1 citations
https://doi.org/10.1038/s41598-024-74215-9
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat